Dr. Yael Porat, CEO of BioGenCell (www.BioGenCell.net), describes the development of a groundbreaking technology for the automated production of personalized stem-cell therapies. These products, derived from the patient’s own blood, will be available on demand within 24 hours, to save lives and restore the quality of life for the billion people worldwide with blood vessel diseases including heart disease, stroke, PAD and dementia.
As part of the Global Entrepreneurship Week, Dr Yael Porat,PHD was invited to speak about BioGencell’s stem cell therapy solution to lecture in front of the younger generation
BioGenCell’s mission is to develop an innovative technology platform that will enable the rapid creation of easy-to-use and cost-effective treatments for a wide range of degenerative diseases using highly standardized therapies derived from adult stem cells.
© 2018 All rights reserved